Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-010874
Filing Date
2025-05-15
Accepted
2025-05-15 16:05:35
Documents
71
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 681208
2 EX-31.1 ex31-1.htm EX-31.1 17518
3 EX-31.2 ex31-2.htm EX-31.2 17537
4 EX-32.1 ex32-1.htm EX-32.1 6717
5 EX-32.2 ex32-2.htm EX-32.2 6588
  Complete submission text file 0001641172-25-010874.txt   4472497

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE vvos-20250331.xsd EX-101.SCH 40382
7 XBRL CALCULATION FILE vvos-20250331_cal.xml EX-101.CAL 54227
8 XBRL DEFINITION FILE vvos-20250331_def.xml EX-101.DEF 139359
9 XBRL LABEL FILE vvos-20250331_lab.xml EX-101.LAB 304247
10 XBRL PRESENTATION FILE vvos-20250331_pre.xml EX-101.PRE 237367
73 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 611346
Mailing Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120
Business Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120 (866)908-4867
Vivos Therapeutics, Inc. (Filer) CIK: 0001716166 (see all company filings)

EIN.: 813224056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39796 | Film No.: 25952691
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)